• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物合成对土壤宏基因组的研究揭示了 Metamarin,一种具有抗活性的不常见环马啉同系物。

Biosynthetic Interrogation of Soil Metagenomes Reveals Metamarin, an Uncommon Cyclomarin Congener with Activity against .

机构信息

Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, 1230 York Avenue, New York, New York 10065, United States.

Rutgers, The State University of New Jersey, International Center for Public Health, 225 Warren Street, Newark, New Jersey 07103, United States.

出版信息

J Nat Prod. 2021 Apr 23;84(4):1056-1066. doi: 10.1021/acs.jnatprod.0c01104. Epub 2021 Feb 23.

DOI:10.1021/acs.jnatprod.0c01104
PMID:33621083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8068612/
Abstract

Tuberculosis (TB) remains one of the deadliest infectious diseases. Unfortunately, the development of antibiotic resistance threatens our current therapeutic arsenal, which has necessitated the discovery and development of novel antibiotics against drug-resistant (). Cyclomarin A and rufomycin I are structurally related cyclic heptapeptides assembled by nonribosomal peptide synthetases (NRPSs), which show potent anti- activity with a new cellular target, the caseinolytic protein ClpC1. An NRPS adenylation domain survey using DNA extracted from ∼2000 ecologically diverse soils found low cyclomarin/rufomycin biosynthetic diversity. In this survey, a family of cyclomarin/rufomycin-like biosynthetic gene clusters (BGC) that encode metamarin, an uncommon cyclomarin congener with potent activity against both H37Rv and multidrug-resistant clinical isolates was identified. Metamarin effectively inhibits growth in murine macrophages and increases the activities of ClpC1 ATPase and the associated ClpC1/P1/P2 protease complex, thus causing cell death by uncontrolled protein degradation.

摘要

结核病(TB)仍然是最致命的传染病之一。不幸的是,抗生素耐药性的发展威胁着我们目前的治疗武器库,这就需要发现和开发针对耐药性的新型抗生素。环马菌素 A 和鲁福霉素 I 是由非核糖体肽合成酶(NRPS)组装的结构相关的环状七肽,它们对新的细胞靶标——组织蛋白酶 ClpC1 表现出强大的抗菌活性。使用从约 2000 种生态多样的土壤中提取的 DNA 对 NRPS 腺苷酸化结构域进行调查,发现环马菌素/鲁福霉素生物合成的多样性较低。在这项调查中,发现了一组环马菌素/鲁福霉素样生物合成基因簇(BGC),它们编码代谢马霉素,这是一种不常见的环马菌素同系物,对 H37Rv 和多药耐药的临床分离株均具有强大的活性。代谢马霉素能有效抑制鼠巨噬细胞中的生长,并增加 ClpC1 ATP 酶和相关的 ClpC1/P1/P2 蛋白酶复合物的活性,从而导致失控的蛋白降解引起细胞死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/bf1510cf7eb0/np0c01104_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/edb9f09b09d7/np0c01104_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/46c9cae0ce3c/np0c01104_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/aabd15299e1f/np0c01104_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/bf1510cf7eb0/np0c01104_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/edb9f09b09d7/np0c01104_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/46c9cae0ce3c/np0c01104_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/aabd15299e1f/np0c01104_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ee/8155385/bf1510cf7eb0/np0c01104_0004.jpg

相似文献

1
Biosynthetic Interrogation of Soil Metagenomes Reveals Metamarin, an Uncommon Cyclomarin Congener with Activity against .生物合成对土壤宏基因组的研究揭示了 Metamarin,一种具有抗活性的不常见环马啉同系物。
J Nat Prod. 2021 Apr 23;84(4):1056-1066. doi: 10.1021/acs.jnatprod.0c01104. Epub 2021 Feb 23.
2
High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.ClpC1-鲁佛霉素的高分辨率结构及配体结合研究为设计和优化抗结核先导化合物提供了框架。
ACS Infect Dis. 2019 Jun 14;5(6):829-840. doi: 10.1021/acsinfecdis.8b00276. Epub 2019 May 3.
3
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.利福霉素靶向结核分枝杆菌和脓肿分枝杆菌的 ClpC1 蛋白酶解。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02204-18. Print 2019 Mar.
4
The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from .抗生素环玛琳阻断 ClpC1 N 端结构域中精氨酸-磷酸诱导的毫秒级动力学。
J Biol Chem. 2018 Jun 1;293(22):8379-8393. doi: 10.1074/jbc.RA118.002251. Epub 2018 Apr 9.
5
The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease.天然产物环马菌素通过靶向酪蛋白水解蛋白酶的ClpC1亚基来杀死结核分枝杆菌。
Angew Chem Int Ed Engl. 2011 Jun 20;50(26):5889-91. doi: 10.1002/anie.201101740. Epub 2011 May 11.
6
Antimycobacterial Rufomycin Analogues from Strain MJM3502.来自 MJM3502 菌株的抗分枝杆菌罗芙木碱类似物。
J Nat Prod. 2020 Mar 27;83(3):657-667. doi: 10.1021/acs.jnatprod.9b01095. Epub 2020 Feb 7.
7
Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide Lassomycin.MtClpC1N 端结构域与抗结核天然肽 Lassomycin 的复合物的晶体结构
Int J Biol Macromol. 2023 Dec 31;253(Pt 2):126771. doi: 10.1016/j.ijbiomac.2023.126771. Epub 2023 Sep 6.
8
A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.一种利用表达荧光素酶的重组牛分枝杆菌卡介苗筛选抗结核药物候选物的新方法。
PLoS One. 2015 Nov 16;10(11):e0141658. doi: 10.1371/journal.pone.0141658. eCollection 2015.
9
Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions.ClpC1 N 端结构域与抗结核天然产物埃卡霉素复合物的结构揭示了独特的结合相互作用。
Acta Crystallogr D Struct Biol. 2020 May 1;76(Pt 5):458-471. doi: 10.1107/S2059798320004027. Epub 2020 Apr 23.
10
Structural basis of mycobacterial inhibition by cyclomarin A.分枝杆菌被环马菌素 A 抑制的结构基础。
J Biol Chem. 2013 Oct 25;288(43):30883-91. doi: 10.1074/jbc.M113.493767. Epub 2013 Sep 10.

引用本文的文献

1
Enhancing rufomycin production by CRISPR/Cas9-based genome editing and promoter engineering in sp. MJM3502.通过基于CRISPR/Cas9的基因组编辑和启动子工程提高链霉菌MJM3502中鲁夫霉素的产量。
Synth Syst Biotechnol. 2025 Jan 17;10(2):421-432. doi: 10.1016/j.synbio.2025.01.002. eCollection 2025 Jun.
2
Total Syntheses of Cyclomarin and Metamarin Natural Products.环马琳和甲马琳天然产物的全合成。
Org Lett. 2024 Nov 15;26(45):9698-9703. doi: 10.1021/acs.orglett.4c03473. Epub 2024 Nov 1.
3
The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles.

本文引用的文献

1
Recent developments in self-resistance gene directed natural product discovery.自我抗性基因导向天然产物发现的最新进展。
Nat Prod Rep. 2020 Jul 1;37(7):879-892. doi: 10.1039/c9np00050j. Epub 2020 Jan 8.
2
Uncovering the biosynthetic potential of rare metagenomic DNA using co-occurrence network analysis of targeted sequences.利用靶向序列共现网络分析揭示稀有宏基因组 DNA 的生物合成潜力。
Nat Commun. 2019 Aug 26;10(1):3848. doi: 10.1038/s41467-019-11658-z.
3
Toxic Activation of an AAA+ Protease by the Antibacterial Drug Cyclomarin A.
含稠合氮杂环天然产物的抗结核活性
Pharmaceuticals (Basel). 2024 Feb 6;17(2):211. doi: 10.3390/ph17020211.
4
Interactome Analysis Identifies MSMEI_3879 as a Substrate of Mycolicibacterium smegmatis ClpC1.相互作用组分析鉴定 MSMEI_3879 为分枝杆菌 smegmatis ClpC1 的底物。
Microbiol Spectr. 2023 Aug 17;11(4):e0454822. doi: 10.1128/spectrum.04548-22. Epub 2023 Jun 21.
5
Present and future outlooks on environmental DNA-based methods for antibiotic discovery.基于环境 DNA 的抗生素发现方法的现状与展望。
Curr Opin Microbiol. 2023 Oct;75:102335. doi: 10.1016/j.mib.2023.102335. Epub 2023 Jun 14.
6
Bioinformatic identification of ClpI, a distinct class of Clp unfoldases in Actinomycetota.放线菌门中一类独特的Clp解折叠酶ClpI的生物信息学鉴定
Front Microbiol. 2023 Apr 17;14:1161764. doi: 10.3389/fmicb.2023.1161764. eCollection 2023.
7
Emulating nonribosomal peptides with ribosomal biosynthetic strategies.采用核糖体生物合成策略模拟非核糖体肽。
RSC Chem Biol. 2022 Dec 6;4(1):7-36. doi: 10.1039/d2cb00169a. eCollection 2023 Jan 4.
8
Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives.**标题**:修饰伊来霉素衍生物的全合成及生物评价
Mar Drugs. 2022 Oct 3;20(10):632. doi: 10.3390/md20100632.
9
Identification of Arginine Phosphorylation in Mycolicibacterium smegmatis.鉴定耻垢分枝杆菌中的精氨酸磷酸化。
Microbiol Spectr. 2022 Oct 26;10(5):e0204222. doi: 10.1128/spectrum.02042-22. Epub 2022 Oct 10.
10
Regulated Expression of an Environmental DNA-Derived Type II Polyketide Gene Cluster in Streptomyces Hosts Identified a New Tetracenomycin Derivative TCM Y.链霉菌宿主中环境DNA来源的II型聚酮化合物基因簇的调控表达鉴定出一种新的四环素霉素衍生物TCM Y。
Curr Microbiol. 2022 Oct 6;79(11):336. doi: 10.1007/s00284-022-03039-5.
抗菌药物环马菌素 A 对 AAA+ 蛋白酶的毒性激活作用。
Cell Chem Biol. 2019 Aug 15;26(8):1169-1179.e4. doi: 10.1016/j.chembiol.2019.05.008. Epub 2019 Jun 13.
4
antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline.antiSMASH 5.0:二次代谢产物基因组挖掘管道的更新。
Nucleic Acids Res. 2019 Jul 2;47(W1):W81-W87. doi: 10.1093/nar/gkz310.
5
High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.ClpC1-鲁佛霉素的高分辨率结构及配体结合研究为设计和优化抗结核先导化合物提供了框架。
ACS Infect Dis. 2019 Jun 14;5(6):829-840. doi: 10.1021/acsinfecdis.8b00276. Epub 2019 May 3.
6
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.利福霉素靶向结核分枝杆菌和脓肿分枝杆菌的 ClpC1 蛋白酶解。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02204-18. Print 2019 Mar.
7
Self-Resistance of Natural Product Producers: Past, Present, and Future Focusing on Self-Resistant Protein Variants.天然产物生产者的自我抵抗:过去、现在和未来——聚焦于自我抵抗的蛋白变体。
ACS Chem Biol. 2018 Jun 15;13(6):1426-1437. doi: 10.1021/acschembio.8b00173. Epub 2018 May 30.
8
Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia.埃塞俄比亚耐药结核病(MDR 和 XDR-TB)的出现及其分子诊断综述。
Microb Pathog. 2018 Apr;117:237-242. doi: 10.1016/j.micpath.2018.02.047. Epub 2018 Feb 24.
9
Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens.非培养依赖性发现马拉菌素作为钙依赖性抗生素,对多药耐药革兰氏阳性病原体具有活性。
Nat Microbiol. 2018 Apr;3(4):415-422. doi: 10.1038/s41564-018-0110-1. Epub 2018 Feb 12.
10
Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.具有不寻常结构单元的伊拉霉素生物合成和增强抗结核药物的工程化生产。
Nat Commun. 2017 Aug 30;8(1):391. doi: 10.1038/s41467-017-00419-5.